gms | German Medical Science

German Congress of Orthopaedics and Traumatology (DKOU 2024)

22. - 25.10.2024, Berlin

Cement augmentation for proximal humerus fractures: A meta-analysis of randomized trials and observational studies

Meeting Abstract

  • presenting/speaker Yannic Lecoultre - LUKS Luzern, University of Lucerne, Luzern, Switzerland
  • Frank J. P. Beeres - Klinik für Orthopädie und Unfallchirurgie, Kantonsspital Luzern LUKS, Luzern, Switzerland
  • Björn-Christian Link - Klinik für Orthopädie und Unfallchirurgie, Kantonsspital Luzern LUKS, Luzern, Switzerland
  • Fabian Pretz - Kantonsspital Luzern LUKS, Luzern, Switzerland
  • Franz Tillmann - Kantonsspital Luzern LUKS, Luzern, Switzerland
  • Reto Babst - Kantonsspital Luzern LUKS, Universität Luzern, Luzern, Switzerland
  • Bryan van de Wall - Klinik für Orthopädie und Unfallchirurgie, Kantonsspital Luzern LUKS, Luzern, Switzerland

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2024). Berlin, 22.-25.10.2024. Düsseldorf: German Medical Science GMS Publishing House; 2024. DocAB84-2045

doi: 10.3205/24dkou455, urn:nbn:de:0183-24dkou4556

Published: October 21, 2024

© 2024 Lecoultre et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objectives: It is unclear if elderly patients treated with plate osteosynthesis for proximal humerus fractures benefit from cement augmentation. This meta-analysis aims to compare cement augmentation to no augmentation regarding healing, complications, and functional results.

Methods: PubMed, Embase and Cochrane Central Register of Controlled Trials were searched for randomized clinical trials and observational studies. Effect estimates were pooled across studies using random effects models. The primary outcome is overall complication rate. Stratified analyses were performed for types of complication (implant related or systemic). Secondary outcomes include re-interventions, hospital stay, operation time, functional scores, and general quality of life.

Results and conclusion: Five observational studies and one randomized controlled trial with a total of 541 patients were included. The overall complication rate was significantly lower in the augmented group (15.6% versus 25.4%, OR 0.54 (95%CI 0.33–0.87)). This was caused by a reduction of implant related complications (10.4% vs 19.9%, OR 0.49 (95%CI 0.28, 0.88)). No difference in humeral head necrosis was found. Data on re-intervention, hospital stay, and operation time was limited but did not show significant differences. No impact on functional scores and general quality of life was detected.

This meta-analysis shows that cement augmentation may reduce overall complications, mainly by preventing implant related complications. No difference was detected regarding need for reintervention, functional scores, general quality of life and hospital stay. This is the first meta-analysis on this topic. It remains to be seen whether conclusions will hold when more and better-quality data becomes available.